Werewolf Therapeutics (NASDAQ:HOWL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Werewolf Therapeutics (HOWL) operate in?

Werewolf Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Werewolf Therapeutics Stock (NASDAQ: HOWL) stock price, news, charts, stock research, profile.

Open	$1.80
Close	$1.71
Volume / Avg.	524.77K / 637.31K
Day Range	$1.70 - $1.81
52 Wk Range	1.66 - 8.19
Market Cap	$76.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	4.64%
Days to Cover	1

Recent News

Top 5 Health Care Stocks That May Fall Off A Cliff This Month

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Lisa Levin

Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.

Lisa Levin

Werewolf Therapeutics' Cancer Drug Shows Promise in Early Study for Solid Tumors, Stock Soars

Werewolf Therapeutics Inc (NASDAQ: HOWL) released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.80
Close	$1.71
Volume / Avg.	524.77K / 637.31K
Day Range	$1.70 - $1.81
52 Wk Range	1.66 - 8.19
Market Cap	$76.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	4.64%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Werewolf Therapeutics (HOWL) stock?

You can purchase shares of Werewolf Therapeutics (NASDAQ:HOWL) through any online brokerage.

View our list of the best stock brokerages

Who are Werewolf Therapeutics (HOWL) competitors?

Other companies in Werewolf Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Invizyne Technologies (NASDAQ:IZTC), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and Aligos Therapeutics (NASDAQ:ALGS).

What is the forecast, or price target, for Werewolf Therapeutics (HOWL) stock?

Werewolf Therapeutics has a consensus price target of $11.88.

What is the current price for Werewolf Therapeutics (HOWL)?

The stock price for Werewolf Therapeutics (NASDAQ: HOWL) is $1.71 last updated November 18, 2024 at 6:40 PM EST.

Does Werewolf Therapeutics (HOWL) pay a dividend?

There are no upcoming dividends for Werewolf Therapeutics.

When is Werewolf Therapeutics (NASDAQ:HOWL) reporting earnings?

Werewolf Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Werewolf Therapeutics (HOWL) going to split?

There is no upcoming split for Werewolf Therapeutics.

What sector and industry does Werewolf Therapeutics (HOWL) operate in?

Werewolf Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Werewolf Therapeutics

Werewolf Therapeutics (HOWL) Forecast